2017 Executive Sponsor
2017 Associate Sponsor
2017 Supporting Partner
2017 Media Partners
Welcome to the 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event taking place February 8-9, 2017 in London. Led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can’t Wait), the program takes on more global examples of disruptive ideas, examples of implementing digital technologies and examples of collaborations to advance clinical trials and to bring therapeutics to patients faster.
Highlights for 2017 include:
-What can we learn from the generated insights real world data is offering to change the outcomes and experience of clinical trials for patients?
– How can we drive innovation in clinical trials into everyday patient care – what are the lessons and the potential benefits to everyday clinical practice?
– Learn from top 10 large pharma on how they are making innovation a reality in their organization.
It was a daunting task to develop the first industry forum on thinking radically different about the way we perform clinical trials, but the result was this conference. The event was first launched in Philadelphia in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.
The first DPharm event addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas.
By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to current day, we are looking at how new innovations will attract and retain more people in clinical trials, bring down development timelines and figure what data is really useful.
With support from MedCity, the British Consulate and NIHR Clinical Research Network, we look forward to bringing more global examples of disrupting clinical trials and to collaborating on an even broader scale between industry and others.
Not all innovation is disruptive. However, as a global community, we can continue to drive down the cost of drug development and provide better access to clinical trials through innovation, while greatly enhancing the patient experience.
We look forward to greeting you at the Millennium Hotel in London on February 8-9, 2017. If you are interested in contributing to our research with a topic suggestion, please contact email@example.com.
Executive Director, Business Development
Jackie Della Torre
Business Development Manager
Conference Logistics Planner
"I thoroughly enjoyed the conference. It was great to hear from such a wide range of knowledgeable speakers and to meet so many like-minded individuals who are enthusiastic about changing the way we do clinical research."
- Sue Collier, GSK
"I really enjoyed the conference and made some useful connections."
- Flóra Raffai, Findacure
"an excellent conference"
- Jane Rhodes, Biogen Idec
"I thoroughly enjoyed DPharm Europe, it was fantastic to see such a huge emphasis on patients and their families at an industry conference!"
- Simon Stones, Generation R
"It was one of the best conferences I have attend in quite some time. The venue, speaker topics, and format had a very light and more personable feel that allowed for learning and networking to be more casual versus other conferences."
- Jen Kelly, HealthiVibe
"Thank you DPharm team: Great content and rich networking opportunities in a really inspiring environment."
- Christian Gossens, Roche Pharmaceuticals